Marginal Impact of Tocilizumab Monotherapy on Anti-HLA Alloantibodies in Highly Sensitized Kidney Transplant Candidates

BACKGROUND. Highly HLA–sensitized kidney transplant candidates are difficult to desensitize, which reduces their chances of receiving a transplant. METHODS. We administered tocilizumab as a monotherapy (8 mg/kg once a mo) to 14 highly sensitized kidney transplant candidates. Highest mean fluorescenc...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Transplant Direct
Main Authors: Daligault, Mélanie, Bardy, Béatrice, Noble, Johan, Bourdin, Anne, Masson, Dominique, Naciri Bennani, Hamza, Bugnazet, Mathilde, Malvezzi, Paolo, Rostaing, Lionel, Jouve, Thomas
Formato: Artigo
Idioma:Inglês
Publicado em: Lippincott Williams & Wilkins 2021
Assuntos:
Kidney Transplantation
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8078280/
https://ncbi.nlm.nih.gov/pubmed/33912657
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/TXD.0000000000001139
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados